ONCS

OncoSec Medical Incorporated

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

ONCS price

OncoSec Medical

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ONCS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ONCS

Valuation

P/E

0.00

Sector -4.26

Industry -4.26

P/BV

0.00

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.08

Industry 2.08

EV/EBITDA

0.26

Sector -546.19

Industry -546.19

EV/EBIT

0.25

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

Sector 1.25

Industry 1.25

P/Net Current Assets

Sector -5.47

Industry -5.47

P/Working Capital

Sector -1.10

Industry -1.10

EPS

-15.66

Sector -1.94

Industry -1.94

BVPS

-2.12

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

0.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

0.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

0.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

738.53%

Sector -61.50%

Industry -61.50%

ROA

-456.75%

Sector -63.85%

Industry -63.85%

ROIC

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

0.26

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

0.25

Sector -10.24

Industry -10.24

Net Debt / Equity

0.32

Sector -0.60

Industry -0.60

Gross Debt / Equity

-0.35

Sector -0.83

Industry -0.83

Equity/Assets

-0.62

Sector 0.43

Industry 0.43

Liabilities/Assets

1.62

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

15.00%

Sector -

Industry -

Fundamentals ONCS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ONCS OncoSec Medical Incorporated	$0.00	-	0.00%	0.00	0.00	738.53%	0.00%
JNJ Johnson & Johnson	$266.66	55.65%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$28.16	23.05%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$258.54	28.04%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.26	-13.44%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$149.54	82.80%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$164.84	5.63%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.95	48.54%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$75.02	-50.44%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$807.71	40.12%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$436.99	56.32%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$106.92	46.57%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$890.51	31.53%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$547.55	41.42%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.13	61.46%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.87	7.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$221.50	62.01%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ONCS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT OncoSec Medical

OncoSec Medical Incorporated

Average Investor10 user rating

4.0 (0 people)

United States

18 years

Founded: 2008

1986

Time since IPO - 40 years

46

Employees

OncoSec Medical Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $-5.49 million.

The company employs approximately 46 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, OncoSec Medical Incorporated reported $- in revenue, generating net income of $-40.52 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ONCS.

Market cap

Net worth

$-5.49 million

$-5,486,461.00

Assets

$8.87 million

$8,871,142.00

Total Shares Outstanding

2.59 million

2,587,000

Average Daily Trading Volume

$1.74 million

$1,736,543.58

Sector

Health Care

Industry

Biotechnology

ONCS

ONCS revenue and profits

Financial Results ONCS

DRAG THE FRAME TO SEE MORE DATA

ONCS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$890.51 31,43% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.13 59,28% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.66 56,57% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$258.54 28,31% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$149.54 86,71% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$164.84 5,67% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$28.16 24,65% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$890.51 31,43% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.13 59,28% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.66 56,57% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$258.54 28,31% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$149.54 86,71% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$164.84 5,67% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$28.16 24,65% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of OncoSec Medical (ONCS) today?

A cotação de OncoSec Medical (ONCS) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de OncoSec Medical (ONCS) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de OncoSec Medical (ONCS) e dados de ações do Ibovespa e mercados internacionais.

Quando OncoSec Medical (ONCS) paga dividendos?

OncoSec Medical (ONCS) não distribuiu dividendos no último ano.

Is OncoSec Medical (ONCS) a good investment?

Atualmente, OncoSec Medical (ONCS) está cotada a US$ 0.00, com um P/L de 0.00, representando um desvio de -4% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy OncoSec Medical (ONCS) stock?

Investir em ações de OncoSec Medical (ONCS) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of OncoSec Medical (ONCS) yield today?

A rentabilidade de OncoSec Medical (ONCS) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de OncoSec Medical (ONCS) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ONCS

OncoSec Medical Incorporated

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ONCS

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ONCS WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT OncoSec Medical

OncoSec Medical Incorporated

United States

18 years

1986

46

PROFIT X PRICE ONCS

Financial Results ONCS

ONCS cash flow

Asset, Revenue and Profit Growth - ONCS

ONCS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions